Literature DB >> 9195930

Close association of the first and fourth extracellular domains of the Duffy antigen/receptor for chemokines by a disulfide bond is required for ligand binding.

C Tournamille1, C Le Van Kim, P Gane, D Blanchard, A E Proudfoot, J P Cartron, Y Colin.   

Abstract

It has been demonstrated that the promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines (DARC) is given by its extracellular NH2-terminal region. However, the relationship among the Fy6, Fya/b, and Fy3 epitopes, localized in the first and fourth extracellular domains of DARC, respectively, and the chemokine binding sites remained a matter of controversy. Here, we performed cross-displacement and cross-inhibition experiments indicating that all anti-Fy6, anti-Fya, and anti-Fy3 monoclonal antibodies and interleukin 8 are antagonists for binding to red cells. Biopanning of phage peptide libraries with an anti-Fy6 monoclonal antibody led to the identification of the motif Phe22-Glu23, the mutation of which altered the binding of both anti-Fy6 and chemokines (interleukin 8, MGSA, RANTES (regulated on activation normal T cell expressed)) to DARC transfectants. These results characterized the core of the Fy6 epitope and provided definitive proof of the tight relationship between Fy6 and the chemokine receptor site. Analysis of red cells treated by sulfhydryl group-modifying reagents suggested that the chemokine receptor function of DARC required the integrity of disulfide bond(s) but not that of free sulfhydryl group(s). Accordingly, mutation of cysteines 51 and 276 abolished chemokine binding to DARC transfectants. Altogether, our results suggested that the chemokine binding pocket of DARC included sequences located in the first and fourth extracellular domains which are brought into close vicinity by a disulfide bridge.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9195930     DOI: 10.1074/jbc.272.26.16274

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  In silico studies on DARC.

Authors:  Alexandre G de Brevern; Ludovic Autin; Yves Colin; Olivier Bertrand; Catherine Etchebest
Journal:  Infect Disord Drug Targets       Date:  2009-06

2.  Molecular evolution of a malaria resistance gene (DARC) in primates.

Authors:  Thiago Yukio Kikuchi Oliveira; Eugene E Harris; Diogo Meyer; Chong K Jue; Wilson Araújo Silva
Journal:  Immunogenetics       Date:  2012-03-07       Impact factor: 2.846

3.  Platelet-Specific Chemokines Contribute to the Pathogenesis of Acute Lung Injury.

Authors:  Khalil Bdeir; Kandace Gollomp; Marta Stasiak; Junjie Mei; Izabela Papiewska-Pajak; Guohua Zhao; G Scott Worthen; Douglas B Cines; Mortimer Poncz; M Anna Kowalska
Journal:  Am J Respir Cell Mol Biol       Date:  2017-02       Impact factor: 6.914

4.  Polymorphism of the Duffy erythrocyte chemokine receptor in Italian patients with Behçet's disease.

Authors:  V Pittoni; S Vaglio; L Magrini; M Accorinti; P Pivetti-Pezzi; G Girelli; G Valesini
Journal:  Rheumatol Int       Date:  2003-01-18       Impact factor: 2.631

5.  Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein.

Authors:  Edwin Chen; Nichole D Salinas; Yining Huang; Francis Ntumngia; Manolo D Plasencia; Michael L Gross; John H Adams; Niraj Harish Tolia
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-18       Impact factor: 11.205

6.  Sequence, evolution and ligand binding properties of mammalian Duffy antigen/receptor for chemokines.

Authors:  Christophe Tournamille; Antoine Blancher; Caroline Le Van Kim; Pierre Gane; Pol André Apoil; Wilson Nakamoto; Jean Pierre Cartron; Yves Colin
Journal:  Immunogenetics       Date:  2004-01-08       Impact factor: 2.846

7.  Identification of mouse Duffy antigen receptor for chemokines (Darc) as a BMD QTL gene.

Authors:  Bouchra Edderkaoui; David J Baylink; Wesley G Beamer; Jon E Wergedal; Ryan Porte; Asok Chaudhuri; Subburaman Mohan
Journal:  Genome Res       Date:  2007-04-06       Impact factor: 9.043

8.  Duffy antigen receptor for chemokines and CXCL5 are essential for the recruitment of neutrophils in a multicellular model of rheumatoid arthritis synovium.

Authors:  Emily Smith; Helen M McGettrick; Michael A Stone; John S Shaw; Jim Middleton; Gerard B Nash; Christopher D Buckley; G Ed Rainger
Journal:  Arthritis Rheum       Date:  2008-07

Review 9.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

10.  Duffy antigen receptor for chemokines and its involvement in patterning and control of inflammatory chemokines.

Authors:  Igor Novitzky-Basso; Antal Rot
Journal:  Front Immunol       Date:  2012-08-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.